Review: The angiogenic and vasodilatory utero-placental network

Placenta

Volumn 32, Issue SUPPL. 2, 2011, Pages

  Valdes G ^a   Corthorn, J ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Angiogenesis; Guinea pig pregnancy; Human pregnancy; Kallikrein kinin system; Utero placental unit; Vasodilation

Indexed keywords

BRADYKININ RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; KALLIKREIN; KININ; MATRIX METALLOPROTEINASE; NITRIC OXIDE; VASCULOTROPIN;

ANGIOGENESIS; CELL MIGRATION; CELL TYPE; CONFERENCE PAPER; ENDOTHELIUM CELL; GENETIC TRANSFECTION; GUINEA PIG; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVASCULARIZATION; SYNCYTIOTROPHOBLAST; TROPHOBLAST; UTERINE ARTERY; UTERUS; VASODILATATION;

ANIMALS; FEMALE; HUMANS; KALLIKREIN-KININ SYSTEM; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PREGNANCY; UTERUS; VASODILATION;

EID: 79952005383     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2011.01.008     Document Type: Conference Paper

References (55)

1. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 2005;99:6-38. (Pubitemid 41366887)
2. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004;25:103-13.
3. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002;87:5290-6. (Pubitemid 35316376)
4. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005;65:550-63. (Pubitemid 40138976)
5. Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002;87:4213-24.
6. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83. (Pubitemid 38364626)
7. Seval Y, Sati L, Celik-Ozenci C, Taskin O, Demir R. The distribution of angiopoietin-1, angiopoietin-2 and their receptors Tie-1 and Tie-2 in the very early human placenta. Placenta 2008;29:809-15.
8. Kontos CD, Cha EH, York JD, Peters KG. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol 2002;22:1704-13. (Pubitemid 34174988)
9. Singh H, Milner CS, Aguilar Hernandez MM, Patel N, Brindle NP. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases. Cell Signal 2009;21:1346-50.
10. Kelly AC, Rodgers A, Dong KW, Barrezueta NX, Blum M, Roberts JL. Gonadotropin-releasing hormone and chorionic gonadotropin gene expression in human placental development. DNA Cell Biol 1991;10:411-21.
11. Berndt S, Blacher S, Perrier d'Hauterive S, Thiry M, Tsampalas M, Cruz A, et al. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. J Clin Endocrinol Metab 2009;94:4567-74.
12. Valdés G, Corthon J, Oyarzún E, Berríos X, Foradori A, Germain AA, et al. Urinary kallikrein excretion in the human menstrual cycle, normal pregnancy and lactation. Prenat Neonat Med 1998;3:1-8.
13. Stone OA, Richer C, Emanueli C, van Weel V, Quax PH, Katare R, et al. Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. Arterioscler Thromb Vasc Biol 2009;29:657-64.
14. Gohlke P, Kuwer I, Schnell A, Amann K, Mall G, Unger T. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1997;29:478-82. (Pubitemid 27074086)
15. Agata J, Chao L, Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension 2002;40:653-9. (Pubitemid 35278601)
16. Novaro V, Colman-Lerner A, Ortega FV, Jawerbaum A, Paz D, Lo Nostro F, et al. Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod Fertil Dev 2001;13:411-20. (Pubitemid 34041457)
17. Desrivieres S, Lu H, Peyri N, Soria C, Legrand Y, Menashi S. Activation of the 92 kDa type IV collagenase by tissue kallikrein. J Cell Physiol 1993;157:587-93. (Pubitemid 23361188)
18. Dvorak HF. Discovery of vascular permeability factor (VPF). Exp Cell Res 2006;312:522-6. (Pubitemid 43290329)
19. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9. (Pubitemid 20066716)
20. Ishihara K, Hayash I, Yamashina S, Majima M. A potential role of bradykinin in angiogenesis and growth of S-180 mouse tumors. Jpn J Pharmacol 2001;87:318-26.
21. Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G, et al. Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res 2008;103:1335-43.
22. Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, et al. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension 2007;49:490-7.
23. Yin H, Chao J, Bader M, Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides 2007;28:1383-9. (Pubitemid 47088743)
24. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009;30:473-82.
25. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13. (Pubitemid 29024678)
26. Ahmed A, Dunk C, Kniss D, Wilkes M. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 1997;76:779-91. (Pubitemid 27260345)
27. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 1998;273:4220-6. (Pubitemid 28103293)
28. Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, et al. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 2006;99:715-22. (Pubitemid 44498305)
29. Cherry PD, Furchgott RF, Zawadzki JV, Jothianandan D. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci U S A 1982;79:2106-10. (Pubitemid 12120806)
30. Gavras H. Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart. Hypertension 1994;23:813-8. (Pubitemid 24180817)
31. Miura S, Matsuo Y, Saku K. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 2003;41:1118-23. (Pubitemid 36548613)
32. Yao YY, Yin H, Shen B, Smith Jr RS, Liu Y, Gao L, et al. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3β pathway. Cardiovasc Res 2008;80:354-64.
33. Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, et al. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 2001;276:16587-91.
34. Silvestre JS, Bergaya S, Tamarat R, Duriez M, Boulanger CM, Levy BI. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ Res 2001;89:678-83.
35. Parenti A, Morbidelli L, Ledda F, Granger HJ, Ziche M. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. Faseb J 2001;15:1487-9.
36. Sanchez de Miguel L, Neysari S, Jakob S, Petrimpol M, Butz N, Banfi A, et al. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart. Cardiovasc Res 2008;80:106-13.
37. Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, et al. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis. Hypertension 2008;51:252-8. (Pubitemid 351159936)
38. Mess A, Zaki N, Kadyrov M, Korr H, Kaufmann P. Caviomorph placentation as a model for trophoblast invasion. Placenta 2007;28:1234-8. (Pubitemid 47570916)
39. Valdés G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 2009;7:79.
40. Valdés G, Chacon C, Corthorn J, Figueroa CD, Germain AM. Tissue kallikrein in human placenta in early and late gestation. Endocrine 2001;14:197-204. (Pubitemid 32436897)
41. Corthorn J, Germain AA, Chacon C, Rey S, Soto GX, Figueroa CD, et al. Expression of kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Endocrine 2006;29:491-9. (Pubitemid 44358840)
42. Valdés G, Erices R, Chacón C, Corthorn J. Angiogenic, hyperpermeability and vasodilator network in utero-placental units along pregnancy in the guineapig (Cavia porcellus). Reprod Biol Endocrinol 2008;6:13.
43. Corthorn J, Rey S, Chacón C, Valdés G. Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guineapig (Cavia porcellus). Reprod Biol Endocrinol 2007;5:27.
44. Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004;2:59.
45. Demir-Weusten AY, Seval Y, Kaufmann P, Demir R, Yucel G, Huppertz B. Matrix metalloproteinases-2, -3 and -9 in human term placenta. Acta Histochem 2007;109:403-12.
46. Morgan T, Craven C, Ward K. Human spiral artery renin-angiotensin system. Hypertension 1998;32:683-7. (Pubitemid 28480544)
47. Broughton Pipkin F, Craven DJ, Symonds EM. The uteroplacental renin-angiotensin system in normal and hypertensive pregnancy. Contrib Nephrol 1981;25:49-52.
48. Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdés G, et al. The uterine placental bed renin-angiotensin system in normal and preeclamptic pregnancy. Endocrinology 2009;150:4316-25.
49. Pinet F, Corvol MT, Bourguignon J, Corvol P. Isolation and characterization of renin-producing human chorionic cells in culture. J Clin Endocrinol Metab 1988;67:1211-20. (Pubitemid 19012955)
50. Celerier J, Cruz A, Lamande N, Gasc JM, Corvol P. Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension 2002;39:224-8. (Pubitemid 34165219)
51. Elebute OA, Mills IH. Urinary kallikrein in normal and hypertensive pregnancies. Perspect Nephrol Hypertens 1976;5:329-38.
52. Salas SP, Rosso P, Espinoza R, Robert JA, Valdés G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol 1993;81:1029-33. (Pubitemid 23168755)
53. Millar JG, Campbell SK, Albano JD, Higgins BR, Clark AD. Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample. Br J Obstet Gynaecol 1996;103:421-6. (Pubitemid 26141631)
54. AbdAlla S, Lother H, el Massiery A, Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001;7:1003-9.
55. Hoegh AM, Borup R, Nielsen FC, Sorensen S, Hviid TV. Gene expression profiling of placentas affected by pre-eclampsia. J Biomed Biotechnol 2010;2010:787545.